英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
commessi查看　commessi　在百度字典中的解释百度英翻中〔查看〕
commessi查看　commessi　在Google字典中的解释Google英翻中〔查看〕
commessi查看　commessi　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • AUSTEDO XR® Medication for Tardive Dyskinesia (TD)
    The most common side effects of AUSTEDO in people with tardive dyskinesia include inflammation of the nose and throat (nasopharyngitis) and problems sleeping (insomnia) The most common side effects of AUSTEDO XR are expected to be similar to AUSTEDO in people with Huntington’s disease or tardive dyskinesia
  • Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine) extended . . .
    The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia Adverse reactions with AUSTEDO XR extended-release tablets are expected to be similar to AUSTEDO tablets Please see full Prescribing Information, including Boxed Warning
  • Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide
    Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD) Includes Austedo side effects, dosage, uses, interactions, and more
  • Austedo | European Medicines Agency (EMA)
    Overview Austedo is a medicine used in adults to treat moderate to severe tardive dyskinesia, a condition where the face, body or both make sudden, irregular movements that cannot be controlled Tardive dyskinesia usually develops as a side effect of certain medicines Austedo contains the active substance deutetrabenazine
  • Austedo for Uncontrolled Movements in Huntington’s and Tardive Dyskinesia
    Austedo (aw-STED-oh) was approved in 2017 and is the first medicine approved to treat both tardive dyskinesia and chorea caused by Huntington’s disease
  • FDA Approves One Pill, Once-Daily Tablets of . . . - Neurology live
    Key Takeaways Deutetrabenazine (Austedo XR) is now available as a once-daily, extended-release tablet for tardive dyskinesia and Huntington disease chorea, enhancing dosing flexibility and adherence The new formulation is available in four strengths (30, 36, 42, and 48 mg) and builds on the original twice-daily dosing options A phase 3 study demonstrated the safety and efficacy of
  • AUSTEDO (deutetrabenazine) tablets - Food and Drug Administration
    2 1 Dosing Information The dose of AUSTEDO is determined individually for each patient based on reduction of chorea or tardive dyskinesia and tolerability When first prescribed to patients who are not being switched from tetrabenazine (a related VMAT2 inhibitor), the recommended starting dose of AUSTEDO is 6 mg administered orally once daily for patients with Huntington’s disease and 12 mg
  • Austedo dosage: Form, strengths, how to take, and more
    Austedo and Austedo XR treat tardive dyskinesia and chorea related to Huntington’s disease in adults The dosage varies depending on the condition Austedo typically starts at 6 mg twice daily
  • Teva Announces FDA Approval of AUSTEDO® (deutetrabenazine) Tablets for . . .
    AUSTEDO ® may cause parkinsonism in patients with Huntington’s disease Sedation is a common dose-limiting adverse reaction of AUSTEDO ® The most common adverse reactions (4% of AUSTEDO ® -treated patients and greater than placebo) in controlled clinical studies of patients with tardive dyskinesia were nasopharyngitis and insomnia
  • FDA approves new doses of Austedo XR for tardive dyskinesia . . . - Healio
    The FDA has approved Austedo XR in four new tablet strengths for adults diagnosed with tardive dyskinesia and chorea associated with Huntington’s disease, according to the manufacturer In a





中文字典-英文字典  2005-2009